SomaSignal Tests for Neurology
Alzheimer's, Parkinson's, and other Neurological Diseases
Discovery/DevelopmentActive
Key Facts
Indication
Alzheimer's, Parkinson's, and other Neurological Diseases
Phase
Discovery/Development
Status
Active
Company
About SomaLogic
Founded in 2000, SomaLogic's mission is to decode the human proteome to revolutionize life sciences and healthcare. Its core achievement is the SomaScan Platform, which leverages proprietary SOMAmer® reagents and KREX™ technology to deliver unparalleled scale, sensitivity, and reproducibility in protein measurement. The company's strategy focuses on providing fee-for-service assay services globally, expanding its menu of SomaSignal diagnostic tests, and leveraging its 2024 merger with Standard BioTools to accelerate leadership in integrated multi-omics solutions.
View full company profile